These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 11451035

  • 1. A study of the effects of the physical characteristics of microcrystalline cellulose on performance in extrusion spheronization.
    Heng PW, Koo OM.
    Pharm Res; 2001 Apr; 18(4):480-7. PubMed ID: 11451035
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
    Fechner PM, Wartewig S, Füting M, Heilmann A, Neubert RH, Kleinebudde P.
    AAPS PharmSci; 2003 Nov 19; 5(4):E31. PubMed ID: 15198519
    [Abstract] [Full Text] [Related]

  • 4. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization.
    Alvarez L, Concheiro A, Gómez-Amoza JL, Souto C, Martínez-Pacheco R.
    Drug Dev Ind Pharm; 2002 Apr 19; 28(4):451-6. PubMed ID: 12056538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N, Kleinebudde P, Puttipipatkhachorn S.
    J Pharm Sci; 2007 Sep 19; 96(9):2469-84. PubMed ID: 17286294
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alternative extrusion-spheronization aids.
    Jain SP, Singh PP, Amin PD.
    Drug Dev Ind Pharm; 2010 Nov 19; 36(11):1364-76. PubMed ID: 20521907
    [Abstract] [Full Text] [Related]

  • 10. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM, Augsburger LL, Pope DG, Shah RD.
    Pharm Dev Technol; 1996 Dec 19; 1(4):325-31. PubMed ID: 9552316
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Approaches to developing fast release pellets via wet extrusion-spheronization.
    Xia Y, Shi CY, Fang JG, Wang WQ.
    Pharm Dev Technol; 2018 Jun 19; 23(5):432-441. PubMed ID: 27882815
    [Abstract] [Full Text] [Related]

  • 15. The influence of liquid binder on the liquid mobility and preparation of spherical granules by the process of extrusion/spheronization.
    Boutell S, Newton JM, Bloor JR, Hayes G.
    Int J Pharm; 2002 May 15; 238(1-2):61-76. PubMed ID: 11996811
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug release mechanism from a microcrystalline cellulose pellet system.
    O'Connor RE, Schwartz JB.
    Pharm Res; 1993 Mar 15; 10(3):356-61. PubMed ID: 8464807
    [Abstract] [Full Text] [Related]

  • 18. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.
    Loka NC, Saripella KK, Pinto CA, Neau SH.
    Drug Dev Ind Pharm; 2018 Apr 15; 44(4):632-642. PubMed ID: 29183166
    [Abstract] [Full Text] [Related]

  • 19. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A, Souto C, Martínez-Pacheco R.
    Eur J Pharm Biopharm; 2011 Nov 15; 79(3):658-63. PubMed ID: 21827853
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.